相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Atezolizumab: A PD-L1-Blocking Antibody for Bladder Cancer
Brant A. Inman et al.
CLINICAL CANCER RESEARCH (2017)
Liquid biopsies come of age: towards implementation of circulating tumour DNA
Jonathan C. M. Wan et al.
NATURE REVIEWS CANCER (2017)
Chemotherapy for Muscle-Invasive Bladder Cancer: Better Late Than Never?
Guru Sonpavde et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Roles of human POLD1 and POLD3 in genome stability
Emanuela Tumini et al.
SCIENTIFIC REPORTS (2016)
Epigenetic alterations in cancer and personalized cancer treatment
Monica Miozzo et al.
FUTURE ONCOLOGY (2015)
ERCC1 as a Prognostic and Predictive Biomarker for Urothelial Carcinoma of the Bladder following Radical Cystectomy
Tobias Klatte et al.
JOURNAL OF UROLOGY (2015)
BRCA1 and CtIP Are Both Required to Recruit Dna2 at Double-Strand Breaks in Homologous Recombination
Nguyen Ngoc Hoa et al.
PLOS ONE (2015)
Diagnostic and prognostic epigenetic biomarkers in cancer
Pedro Costa-Pinheiro et al.
EPIGENOMICS (2015)
Muscle-invasive urothelial bladder cancer: an update on systemic therapy
Hayley Knollman et al.
THERAPEUTIC ADVANCES IN UROLOGY (2015)
Chromatin structure, transcriptional activity and DNA repair efficiency affect the outcome of chemotherapy in multiple myeloma
M. Gkotzamanidou et al.
BRITISH JOURNAL OF CANCER (2014)
Epigenetic inactivation of ITIH5 promotes bladder cancer progression and predicts early relapse of pT1 high-grade urothelial tumours
Michael Rose et al.
CARCINOGENESIS (2014)
ERCC1-Positive Circulating Tumor Cells in the Blood of Ovarian Cancer Patients as a Predictive Biomarker for Platinum Resistance
Jan Dominik Kuhlmann et al.
CLINICAL CHEMISTRY (2014)
APC/CCdh1 controls CtIP stability during the cell cycle and in response to DNA damage
Lorenzo Lafranchi et al.
EMBO JOURNAL (2014)
Accurate detection of upper tract urothelial carcinoma in tissue and urine by means of quantitative GDF15, TMEFF2 and VIM promoter methylation
Sara Monteiro-Reis et al.
EUROPEAN JOURNAL OF CANCER (2014)
Combination of CK20 and Ki-67 Immunostaining Analysis Predicts Recurrence, Progression, and Cancer-Specific Survival in pT1 Urothelial Bladder Cancer
Simone Bertz et al.
EUROPEAN UROLOGY (2014)
Epigenetic Inactivation of the BRCA1 Interactor SRBC and Resistance to Oxaliplatin in Colorectal Cancer
Catia Moutinho et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Emergence and Evolutionary Analysis of the Human DDR Network: Implications in Comparative Genomics and Downstream Analyses
Aida Arcas et al.
MOLECULAR BIOLOGY AND EVOLUTION (2014)
Triapine Disrupts CtIP-Mediated Homologous Recombination Repair and Sensitizes Ovarian Cancer Cells to PARP and Topoisomerase Inhibitors
Z. Ping Lin et al.
MOLECULAR CANCER RESEARCH (2014)
Catalytic and Noncatalytic Roles of the CtIP Endonuclease in Double-Strand Break End Resection
Nodar Makharashvili et al.
MOLECULAR CELL (2014)
Comprehensive molecular characterization of urothelial bladder carcinoma
John N. Weinstein et al.
NATURE (2014)
A Genomic Instability Score in Discriminating Nonequivalent Outcomes of BRCA1/2 Mutations and in Predicting Outcomes of Ovarian Cancer Treated with Platinum-Based Chemotherapy
Shaojun Zhang et al.
PLOS ONE (2014)
BRCA1 Accelerates CtIP-Mediated DNA-End Resection
Andres Cruz-Garcia et al.
CELL REPORTS (2014)
Pan-cancer patterns of DNA methylation
Tania Witte et al.
GENOME MEDICINE (2014)
DNA methylation profiles of long- and short-term glioblastoma survivors
Thoraia Shinawi et al.
EPIGENETICS (2013)
Microsatellite instability induced mutations in DNA repair genes CtIP and MRE11 confer hypersensitivity to poly (ADP-ribose) polymerase inhibitors in myeloid malignancies
Terry J. Gaymes et al.
HAEMATOLOGICA (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
Emerging landscape of oncogenic signatures across human cancers
Giovanni Ciriello et al.
NATURE GENETICS (2013)
The Cancer Genome Atlas Pan-Cancer analysis project
John N. Weinstein et al.
NATURE GENETICS (2013)
Exploring TCGA Pan-Cancer Data at the UCSC Cancer Genomics Browser
Melissa S. Cline et al.
SCIENTIFIC REPORTS (2013)
Prognostic value of CtIP/RBBP8 expression in breast cancer
Isabel Soria-Bretones et al.
CANCER MEDICINE (2013)
ERCC1 as a biomarker for bladder cancer patients likely to benefit from adjuvant chemotherapy
Jong-Mu Sun et al.
BMC CANCER (2012)
BRCA1 epigenetic inactivation predicts sensitivity to platinum-based chemotherapy in breast and ovarian cancer
Olafur A. Stefansson et al.
EPIGENETICS (2012)
Make way for the 'next generation': application and prospects for genome-wide, epigenome-specific technologies in endocrine research
Richard D. Emes et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2012)
A DNA Repair Pathway-Focused Score for Prediction of Outcomes in Ovarian Cancer Treated With Platinum-Based Chemotherapy
Josephine Kang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Molecular mechanisms of cisplatin resistance
L. Galluzzi et al.
ONCOGENE (2012)
O6-Methylguanine-DNA methyltransferase (MGMT) in normal tissues and tumors: Enzyme activity, promoter methylation and immunohistochemistry
Markus Christmann et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2011)
The WHO classification of 1973 is more suitable than the WHO classification of 2004 for predicting survival in pT1 urothelial bladder cancer
Wolfgang Otto et al.
BJU INTERNATIONAL (2011)
High density DNA methylation array with single CpG site resolution
Marina Bibikova et al.
GENOMICS (2011)
Therapeutic Potential of Poly(ADP-ribose) Polymerase Inhibitor AG014699 in Human Cancers With Mutated or Methylated BRCA1 or BRCA2
Yvette Drew et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
CtIP and MRN promote non-homologous end-joining of etoposide-induced DNA double-strand breaks in G1
Verena Quennet et al.
NUCLEIC ACIDS RESEARCH (2011)
Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis
Pan Du et al.
BMC BIOINFORMATICS (2010)
Unique DNA Methylation Patterns Distinguish Noninvasive and Invasive Urothelial Cancers and Establish an Epigenetic Field Defect in Premalignant Tissue
Erika M. Wolff et al.
CANCER RESEARCH (2010)
DNA end resection by CtIP and exonuclease 1 prevents genomic instability
Wassim Eid et al.
EMBO REPORTS (2010)
BRCA1 CpG Island Hypermethylation Predicts Sensitivity to Poly(Adenosine Diphosphate)-Ribose Polymerase Inhibitors
Jurgen Veeck et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Cisplatin sensitivity of testis tumour cells is due to deficiency in interstrand-crosslink repair and low ERCC1-XPF expression
Svetlana Usanova et al.
MOLECULAR CANCER (2010)
The DNA Damage Response: Making It Safe to Play with Knives
Alberto Ciccia et al.
MOLECULAR CELL (2010)
Allele-specific copy number analysis of tumors
Peter Van Loo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
MDR1 and ERCC1 Expression Predict Outcome of Patients with Locally Advanced Bladder Cancer Receiving Adjuvant Chemotherapy
Andreas-Claudius Hoffmann et al.
NEOPLASIA (2010)
Prediction of breast cancer sensitivity to neoadjuvant chemotherapy based on status of DNA damage repair proteins
Hideki Asakawa et al.
BREAST CANCER RESEARCH (2010)
Utility of Gene Promoter Methylation in Prediction of Response to Platinum-Based Chemotherapy in Epithelial Ovarian Cancer (EOC)
Parvesh Chaudhry et al.
CANCER INVESTIGATION (2009)
Expression of PCNA-binding domain of CtIP, a motif required for CtIP localization at DNA replication foci, causes DNA damage and activation of DNA damage checkpoint
Bingnan Gu et al.
CELL CYCLE (2009)
CtIP-BRCA1 modulates the choice of DNA double-strand-break repair pathway throughout the cell cycle
Maximina H. Yun et al.
NATURE (2009)
Economic aspects of bladder cancer: what are the benefits and costs?
K. D. Sievert et al.
WORLD JOURNAL OF UROLOGY (2009)
Patients' perceived burden of cystoscopic and urinary surveillance of bladder cancer: a randomized comparison
Madelon N. M. van der Aa et al.
BJU INTERNATIONAL (2008)
Alternative-NHEJ Is a Mechanistically Distinct Pathway of Mammalian Chromosome Break Repair
Nicole Bennardo et al.
PLOS GENETICS (2008)
Human CtIP promotes DNA end resection
Alessandro A. Sartori et al.
NATURE (2007)
CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer
Daniel J. Weisenberger et al.
NATURE GENETICS (2006)
Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis
J. Veeck et al.
ONCOGENE (2006)
Bladder cancer predisposition: A multigenic approach to DNA-repair and cell-cycle-control genes
XF Wu et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Matlnspector and beyond: promoter analysis based on transcription factor binding sites
K Cartharius et al.
BIOINFORMATICS (2005)
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
J Bartkova et al.
NATURE (2005)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
MethPrimer: designing primers for methylation PCRs
LC Li et al.
BIOINFORMATICS (2002)
Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents
M Esteller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Nuclear localization and cell cycle-specific expression of CtIP, a protein that associates with the BRCA1 tumor suppressor
X Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors
M Esteller et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
